Someone else made the point but it just clicked for me. Last Cap Raise was 1/10/19 and on 19/10/19 MSB entered into agreement with Lonza for manufacturing of Ryoncil in preparation for commercial launch in paediatric GvHD. That was for $75mil in an indication immensely smaller than the current Covid-19 ARDS needs. I wonder if how much of that cap raise was prompted at the request of Lonza. By the same token I wonder if there was any promoting here and if there will be will be a subsequent announcement in 2 weeks announcing an agreement with Lonza for manufacturing Ryoncil in preparation for a commercial launch in ARDS.
Re: Ann: Trading Halt, page-2
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |